Literature DB >> 17013560

Toxicity of statins on rat skeletal muscle mitochondria.

P Kaufmann1, M Török, A Zahno, K M Waldhauser, K Brecht, S Krähenbühl.   

Abstract

We investigated mitochondrial toxicity of four lipophilic stains (cerivastatin, fluvastatin, atorvastatin, simvastatin) and one hydrophilic statin (pravastatin). In L6 cells (rat skeletal muscle cell line), the four lipophilic statins (100 micromol/l) induced death in 27-49% of the cells. Pravastatin was not toxic up to 1 mmol/l. Cerivastatin, fluvastatin and atorvastatin (100 micromol/l) decreased the mitochondrial membrane potential by 49-65%, whereas simvastatin and pravastatin were less toxic. In isolated rat skeletal muscle mitochondria, all statins, except pravastatin, decreased glutamate-driven state 3 respiration and respiratory control ratio. Beta-oxidation was decreased by 88-96% in the presence of 100 micromol/l of the lipophilic statins, but only at higher concentrations by pravastatin. Mitochondrial swelling, cytochrome c release and DNA fragmentation was induced in L6 cells by the four lipophilic statins, but not by pravastatin. Lipophilic statins impair the function of skeletal muscle mitochondria, whereas the hydrophilic pravastatin is significantly less toxic.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17013560     DOI: 10.1007/s00018-006-6235-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  65 in total

1.  Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury.

Authors:  Yan Yu; Hong Jin; Daniel Holder; Josef S Ozer; Stephanie Villarreal; Paul Shughrue; Shu Shi; David J Figueroa; Holly Clouse; Ming Su; Nagaraja Muniappa; Sean P Troth; Wendy Bailey; John Seng; Amy G Aslamkhan; Douglas Thudium; Frank D Sistare; David L Gerhold
Journal:  Nat Biotechnol       Date:  2010-05       Impact factor: 54.908

Review 2.  Is immunity a mechanism contributing to statin-induced diabetes?

Authors:  Brandyn D Henriksbo; Jonathan D Schertzer
Journal:  Adipocyte       Date:  2015-04-20       Impact factor: 4.534

3.  Fluvastatin-induced alterations of skeletal muscle function in hypercholesterolaemic rats.

Authors:  Márta Füzi; Zoltán Palicz; János Vincze; Julianna Cseri; Zita Szombathy; Ilona Kovács; Anna Oláh; Péter Szentesi; Pál Kertai; György Paragh; László Csernoch
Journal:  J Muscle Res Cell Motil       Date:  2011-11-09       Impact factor: 2.698

4.  Atorvastatin is 10-fold more active in vitro than other statins against Plasmodium falciparum.

Authors:  Bruno Pradines; Marylin Torrentino-Madamet; Albin Fontaine; Maud Henry; Eric Baret; Joel Mosnier; Sébastien Briolant; Thierry Fusai; Christophe Rogier
Journal:  Antimicrob Agents Chemother       Date:  2007-05-14       Impact factor: 5.191

5.  The battle to keep or lose skeletal muscle with ageing.

Authors:  Michael Kjaer; Jakob G Jespersen
Journal:  J Physiol       Date:  2009-01-15       Impact factor: 5.182

6.  Mitophagy protects against statin-mediated skeletal muscle toxicity.

Authors:  Mridula Ramesh; Juliane C Campos; Pamela Lee; Yang Song; Genaro Hernandez; Jon Sin; Kyle C Tucker; Hannaneh Saadaeijahromi; Michael Gurney; Julio C B Ferreira; Allen M Andres
Journal:  FASEB J       Date:  2019-08-23       Impact factor: 5.191

7.  Involvement of organic anion transporting polypeptides in the toxicity of hydrophilic pravastatin and lipophilic fluvastatin in rat skeletal myofibres.

Authors:  K Sakamoto; H Mikami; J Kimura
Journal:  Br J Pharmacol       Date:  2008-05-26       Impact factor: 8.739

8.  Tissue-Engineered Human Myobundle System as a Platform for Evaluation of Skeletal Muscle Injury Biomarkers.

Authors:  Alastair Khodabukus; Amulya Kaza; Jason Wang; Neel Prabhu; Richard Goldstein; Vishal S Vaidya; Nenad Bursac
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

9.  The muscle-specific ubiquitin ligase atrogin-1/MAFbx mediates statin-induced muscle toxicity.

Authors:  Jun-ichi Hanai; Peirang Cao; Preeti Tanksale; Shintaro Imamura; Eriko Koshimizu; Jinghui Zhao; Shuji Kishi; Michiaki Yamashita; Paul S Phillips; Vikas P Sukhatme; Stewart H Lecker
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

10.  Simvastatin impairs exercise training adaptations.

Authors:  Catherine R Mikus; Leryn J Boyle; Sarah J Borengasser; Douglas J Oberlin; Scott P Naples; Justin Fletcher; Grace M Meers; Meghan Ruebel; M Harold Laughlin; Kevin C Dellsperger; Paul J Fadel; John P Thyfault
Journal:  J Am Coll Cardiol       Date:  2013-04-10       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.